A citation-based method for searching scientific literature

Anna Adamska-Wełnicka, Marcin Wełnicki, Artur Mamcarz, Ryszard Gellert. Diagnostics (Basel) 2021
Times Cited: 4







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Theresa A McDonagh, Marco Metra, Marianna Adamo, Roy S Gardner, Andreas Baumbach, Michael Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Chioncel,[...]. Eur Heart J 2021
75

Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide.
Uzoma N Ibebuogu, Inna P Gladysheva, Aiilyan K Houng, Guy L Reed. Circ Heart Fail 2011
95
50

Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.
V J Dzau, W S Colucci, N K Hollenberg, G H Williams. Circulation 1981
483
50

Progression of Renal Impairment and Chronic Kidney Disease in Chronic Heart Failure: An Analysis From GISSI-HF.
Kevin Damman, Serge Masson, Donata Lucci, Marco Gorini, Renato Urso, Aldo P Maggioni, Luigi Tavazzi, Luigi Tarantini, Gianni Tognoni, Adriaan Voors,[...]. J Card Fail 2017
16
50

Renin Activity in Heart Failure with Reduced Systolic Function-New Insights.
Ryan D Sullivan, Radhika M Mehta, Ranjana Tripathi, Guy L Reed, Inna P Gladysheva. Int J Mol Sci 2019
15
50

A Low-Sodium Diet Boosts Ang (1-7) Production and NO-cGMP Bioavailability to Reduce Edema and Enhance Survival in Experimental Heart Failure.
Ranjana Tripathi, Ryan D Sullivan, Tai-Hwang M Fan, Radhika M Mehta, Inna P Gladysheva, Guy L Reed. Int J Mol Sci 2021
6
50

Enhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy.
Ranjana Tripathi, Ryan Sullivan, Tai-Hwang M Fan, Dong Wang, Yao Sun, Guy L Reed, Inna P Gladysheva. PLoS One 2017
16
50

Normalizing Plasma Renin Activity in Experimental Dilated Cardiomyopathy: Effects on Edema, Cachexia, and Survival.
Ryan D Sullivan, Radhika M Mehta, Ranjana Tripathi, Inna P Gladysheva, Guy L Reed. Int J Mol Sci 2019
9
50

Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.
Janani Rangaswami, Vivek Bhalla, John E A Blair, Tara I Chang, Salvatore Costa, Krista L Lentine, Edgar V Lerma, Kenechukwu Mezue, Mark Molitch, Wilfried Mullens,[...]. Circulation 2019
365
50


Pulmonary Congestion Assessment in Heart Failure: Traditional and New Tools.
Filippo Pirrotta, Benedetto Mazza, Luigi Gennari, Alberto Palazzuoli. Diagnostics (Basel) 2021
5
50

Possible Enzymatic Downregulation of the Natriuretic Peptide System in Patients with Reduced Systolic Function and Heart Failure: A Pilot Study.
Syed S Zaidi, Ryan D Ward, Kodangudi Ramanathan, Xinhua Yu, Inna P Gladysheva, Guy L Reed. Biomed Res Int 2018
15
50


Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
Ranjana Tripathi, Dong Wang, Ryan Sullivan, Tai-Hwang M Fan, Inna P Gladysheva, Guy L Reed. Hypertension 2016
34
50

Heart failure and kidney dysfunction: epidemiology, mechanisms and management.
Joerg C Schefold, Gerasimos Filippatos, Gerd Hasenfuss, Stefan D Anker, Stephan von Haehling. Nat Rev Nephrol 2016
250
50

Sodium-Glucose Cotransporter-2 Inhibitors Improve Heart Failure with Reduced Ejection Fraction Outcomes by Reducing Edema and Congestion.
Michelle Hernandez, Ryan D Sullivan, Mariana E McCune, Guy L Reed, Inna P Gladysheva. Diagnostics (Basel) 2022
4
50

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
25

Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure.
Jorge Rubio-Gracia, Biniyam G Demissei, Jozine M Ter Maaten, John G Cleland, Christopher M O'Connor, Marco Metra, Piotr Ponikowski, John R Teerlink, Gad Cotter, Beth A Davison,[...]. Int J Cardiol 2018
96
25

Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects.
Jason R B Dyck, Samuel Sossalla, Nazha Hamdani, Ruben Coronel, Nina C Weber, Peter E Light, Coert J Zuurbier. J Mol Cell Cardiol 2022
5
25

Canagliflozin for Japanese patients with chronic heart failure and type II diabetes.
Akira Sezai, Hisakuni Sekino, Satoshi Unosawa, Makoto Taoka, Shunji Osaka, Masashi Tanaka. Cardiovasc Diabetol 2019
36
25


Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry.
Ovidiu Chioncel, Alexandre Mebazaa, Veli-Pekka Harjola, Andrew J Coats, Massimo Francesco Piepoli, Maria G Crespo-Leiro, Cecile Laroche, Petar M Seferovic, Stefan D Anker, Roberto Ferrari,[...]. Eur J Heart Fail 2017
203
25

Clinical practice. Acute pulmonary edema.
Lorraine B Ware, Michael A Matthay. N Engl J Med 2005
324
25

An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER).
Fumiki Yoshihara, Miki Imazu, Toshimitsu Hamasaki, Toshihisa Anzai, Satoshi Yasuda, Shin Ito, Haruko Yamamoto, Kazuhiko Hashimura, Yoshio Yasumura, Kiyoshi Mori,[...]. Cardiovasc Drugs Ther 2018
5
25


Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction: A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial.
Jawad H Butt, Kieran F Docherty, Mark C Petrie, Morten Schou, Mikhail N Kosiborod, Eileen O'Meara, Tzvetana Katova, Charlotta E A Ljungman, Mirta Diez, Modele O Ogunniyi,[...]. JAMA Cardiol 2021
9
25

The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats.
Hsiang-Chun Lee, Yi-Lin Shiou, Shih-Jie Jhuo, Chia-Yuan Chang, Po-Len Liu, Wun-Jyun Jhuang, Zen-Kong Dai, Wei-Yu Chen, Yun-Fang Chen, An-Sheng Lee. Cardiovasc Diabetol 2019
79
25

Water and sodium in heart failure: a spotlight on congestion.
Gaspare Parrinello, Stephen J Greene, Daniele Torres, Michael Alderman, Joseph Vincent Bonventre, Pietro Di Pasquale, Luna Gargani, Anju Nohria, Gregg C Fonarow, Muthiah Vaduganathan,[...]. Heart Fail Rev 2015
26
25

Cardiac effects of SGLT2 inhibitors: the sodium hypothesis.
Edoardo Bertero, Leticia Prates Roma, Pietro Ameri, Christoph Maack. Cardiovasc Res 2018
83
25


Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study.
Juan Antonio Requena-Ibáñez, Carlos G Santos-Gallego, Anderly Rodriguez-Cordero, Ariana P Vargas-Delgado, Donna Mancini, Samantha Sartori, Farah Atallah-Lajam, Chiara Giannarelli, Frank Macaluso, Anuradha Lala,[...]. JACC Heart Fail 2021
55
25

SGLT2-inhibitors; more than just glycosuria and diuresis.
Amir Fathi, Keeran Vickneson, Jagdeep S Singh. Heart Fail Rev 2021
16
25

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Mark H Drazner, Gregg C Fonarow, Stephen A Geraci, Tamara Horwich, James L Januzzi,[...]. Circulation 2013
25

Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.
Yao Hao Teo, Yao Neng Teo, Nicholas L Syn, Cheryl Shumin Kow, Celine Shuen Yin Yoong, Benjamin Y Q Tan, Tiong-Cheng Yeo, Chi-Hang Lee, Weiqin Lin, Ching-Hui Sia. J Am Heart Assoc 2021
24
25

Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications.
Vojtech Melenovsky, Mads J Andersen, Krystof Andress, Yogesh N Reddy, Barry A Borlaug. Eur J Heart Fail 2015
91
25


Wet is bad: Residual congestion predicts worse prognosis in acute heart failure.
Alberto Aimo, Giuseppe Vergaro, Alberto Giannoni, Michele Emdin. Int J Cardiol 2018
5
25


Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.
Alice M Jackson, Pooja Dewan, Inder S Anand, Jan Bělohlávek, Olof Bengtsson, Rudolf A de Boer, Michael Böhm, David W Boulton, Vijay K Chopra, David L DeMets,[...]. Circulation 2020
67
25

Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?
Michele Correale, Renata Petroni, Stefano Coiro, Elena-Laura Antohi, Francesco Monitillo, Marta Leone, Marco Triggiani, Shiro Ishihara, Hans-Dirk Dungen, Chaudhry M S Sarwar,[...]. Heart Fail Rev 2022
3
33

Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
Yuliya Lytvyn, Petter Bjornstad, Jacob A Udell, Julie A Lovshin, David Z I Cherney. Circulation 2017
255
25

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.
Faiez Zannad, João Pedro Ferreira, Stuart J Pocock, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Martina Brueckmann, Anne Pernille Ofstad, Egon Pfarr, Waheed Jamal,[...]. Lancet 2020
481
25

Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure.
Moritz J Hundertmark, Olorunsola F Agbaje, Ruth Coleman, Jyothis T George, Rolf Grempler, Rury R Holman, Hanan Lamlum, Jisoo Lee, Joanne E Milton, Heiko G Niessen,[...]. ESC Heart Fail 2021
9
25

Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.
Senthil Selvaraj, Brian Claggett, Andrea Pozzi, John J V McMurray, Pardeep S Jhund, Milton Packer, Akshay S Desai, Eldrin F Lewis, Muthiah Vaduganathan, Martin P Lefkowitz,[...]. Circulation 2019
48
25

EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot).
Aldo P Maggioni, Ulf Dahlström, Gerasimos Filippatos, Ovidiu Chioncel, Marisa Crespo Leiro, Jaroslaw Drozdz, Friedrich Fruhwald, Lars Gullestad, Damien Logeart, Marco Metra,[...]. Eur J Heart Fail 2010
283
25



A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).
John J V McMurray, David L DeMets, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Anna M Langkilde, Felipe A Martinez, Olof Bengtsson, Piotr Ponikowski, Marc S Sabatine,[...]. Eur J Heart Fail 2019
169
25

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.
Mikhail N Kosiborod, Pardeep S Jhund, Kieran F Docherty, Mirta Diez, Mark C Petrie, Subodh Verma, Jose C Nicolau, Béla Merkely, Masafumi Kitakaze, David L DeMets,[...]. Circulation 2020
151
25

Altered Hemodynamics and End-Organ Damage in Heart Failure: Impact on the Lung and Kidney.
Frederik H Verbrugge, Marco Guazzi, Jeffrey M Testani, Barry A Borlaug. Circulation 2020
56
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.